Guidelines do matter.
作者信息
Anthonisen N
机构信息
Department of Internal Medicine, University of Manitoba, Winnipeg, Man.
出版信息
CMAJ. 2001 Mar 6;164(5):641-2.
Abstract
摘要
相似文献
1
Guidelines do matter.指南确实很重要。
CMAJ. 2001 Mar 6;164(5):641-2.
2
3
Setting the gold standard: clinical and economic decision making in asthma management.确立金标准：哮喘管理中的临床与经济决策
Manag Care. 2003 Jan;12(1 Suppl):11-7.
4
Tolerance...can be a respiratory dilemma.耐受性……可能是一个呼吸方面的难题。
J Ky Med Assoc. 2005 Sep;103(9):465.
5
Inhaled corticosteroids are safe even for young asthma patients.吸入性糖皮质激素对年轻哮喘患者来说也是安全的。
Rep Med Guidel Outcomes Res. 2002 Jul 12;13(13):5-8.
6
Pharmacy fill patterns in young urban children with persistent asthma.城市中患有持续性哮喘的幼儿的配药模式。
J Asthma. 2006 Oct;43(8):597-600. doi: 10.1080/02770900600878537.
7
Long-acting beta-2 agonists in asthma.哮喘治疗中的长效β2受体激动剂
Med Lett Drugs Ther. 2009 Jan 12;51(1303):1-2.
8
Asthma in New Zealand--time to get control.新西兰的哮喘——是时候加以控制了。
N Z Med J. 2003 May 16;116(1174):U434.
9
Prescribing patterns of anti-asthma drugs in pediatric patients.儿科患者抗哮喘药物的处方模式。
Acta Paediatr Taiwan. 2005 Jul-Aug;46(4):212-8.
10
[Improvement of compliance in the therapy of asthma--what about evidence and how can the effect be evaluated?].[改善哮喘治疗的依从性——证据如何以及如何评估效果？]
Dtsch Med Wochenschr. 2009 Dec;134 Suppl 10:S394-7. doi: 10.1055/s-0029-1243049. Epub 2009 Nov 25.
本文引用的文献
1
Double trouble: impact of inappropriate use of asthma medication on the use of health care resources.双重麻烦：哮喘药物使用不当对医疗资源利用的影响
CMAJ. 2001 Mar 6;164(5):625-31.
2
Canadian Asthma Consensus Report, 1999. Canadian Asthma Consensus Group.《1999年加拿大哮喘共识报告》。加拿大哮喘共识小组。
CMAJ. 1999 Nov 30;161(11 Suppl):S1-61.
3
Income level and asthma prevalence and care patterns.收入水平与哮喘患病率及护理模式。
Am J Respir Crit Care Med. 1997 Mar;155(3):1060-5. doi: 10.1164/ajrccm.155.3.9116987.
4
Comparison of regularly scheduled with as-needed use of albuterol in mild asthma. Asthma Clinical Research Network.轻度哮喘中按需使用沙丁胺醇与定期使用的比较。哮喘临床研究网络。
N Engl J Med. 1996 Sep 19;335(12):841-7. doi: 10.1056/NEJM199609193351202.
5
Is the association between inhaled beta-agonist use and life-threatening asthma because of confounding by severity?吸入性β-受体激动剂的使用与因严重程度混淆导致的危及生命的哮喘之间是否存在关联？
Am Rev Respir Dis. 1993 Jul;148(1):75-9. doi: 10.1164/ajrccm/148.1.75.
6
Regular inhaled beta-agonist treatment in bronchial asthma.支气管哮喘的常规吸入β-激动剂治疗
Lancet. 1990 Dec 8;336(8728):1391-6. doi: 10.1016/0140-6736(90)93098-a.
7
The use of beta-agonists and the risk of death and near death from asthma.β-激动剂的使用与哮喘导致的死亡及濒死风险
N Engl J Med. 1992 Feb 20;326(8):501-6. doi: 10.1056/NEJM199202203260801.
Zotero 插件